Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.47 CAD | -5.16% | -9.82% | -56.12% |
05-14 | Transcript : Aptose Biosciences Inc., Q1 2024 Earnings Call, May 14, 2024 | |
05-14 | Aptose Biosciences Q1 Net Loss Falls, on Lower Expenses | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-56.12% | 17.5M | |
+64.92% | 62.86B | |
-1.85% | 41.38B | |
+45.94% | 40.38B | |
-8.93% | 27.64B | |
+13.05% | 26.46B | |
-21.96% | 18.9B | |
+4.21% | 12.67B | |
+25.74% | 12.27B | |
+27.42% | 12.07B |
- Stock Market
- Equities
- APS Stock
- News Aptose Biosciences Inc.
- Aptose Biosciences Brief: Presenting Highlights from Clinical Update Webcast Featuring Latest Available Data on AML Drug Tuspetinib